World Solve

Resistant malaria strains have emerged in certain regions and are gradually spreading, threatening to undermine decades of progress against the disease. Coordinated, faster response to contain resistance before it spreads further remains incomplete.

Some people who die of sudden cardiac events had no known risk factors or warning signs beforehand, suggesting current screening methods miss a meaningful share of at-risk individuals. Better detection tools for this group remain an open need.

Some patients with autoimmune diseases experience unexplained periods of remission without clear treatment causes, while others never do. Understanding this could reveal new treatment pathways currently hidden within the body's own natural mechanisms.

Low-grade chronic inflammation is linked to numerous diseases, yet in many patients there's no clear infection or injury explaining why it continues. Understanding this could unlock treatments for a wide range of related conditions.

This parasitic disease continues to cause preventable blindness in parts of Africa and Latin America, largely due to limited access to consistent treatment. Expanding affordable access remains the main barrier rather than lack of an effective treatment.

Many patients with chronic conditions end up back in the hospital shortly after being discharged, often due to gaps in follow-up care rather than a failure of the original treatment. Better post-discharge support remains an unresolved healthcare system issue.

Some diseases occur far more frequently within certain populations due to genetic factors that aren't yet fully mapped or understood. Filling this knowledge gap could lead to more targeted prevention and treatment.

Many cancer survivors continue to experience pain long after their cancer treatment concludes, and this pain is often undertreated because it's assumed to have resolved along with the disease. Better long-term pain management for survivors remains an overlooked need.

Some patients continue experiencing symptoms long after completing standard treatment for Lyme disease, and doctors disagree on both the cause and the best way to treat this lingering illness. Resolving this uncertainty remains a significant unmet need.

This parasitic disease affects millions in tropical and subtropical regions, but effective treatment remains expensive, difficult to access, or logistically challenging for many affected communities. Closing this access gap remains unresolved.

Chronic stress is linked to heart disease, digestive problems, and other physical illnesses, but why some people are more vulnerable to these effects than others isn't fully explained. Understanding this could improve both prevention and treatment.

The vast majority of autoimmune disease diagnoses occur in women, and the biological reasons behind this imbalance remain only partially understood. A clearer answer could open new treatment approaches for both sexes.

COPD gradually reduces lung function over years, and while treatment can ease symptoms and slow decline, it can't reverse the underlying lung damage. A cure remains out of reach for the millions living with this condition.

Effective vaccines exist for a small number of sexually transmitted infections, but many common ones still have no vaccine available at all. Expanding vaccine coverage here could significantly reduce global disease burden.

People with celiac disease must avoid gluten completely for life, since no treatment currently exists to let them safely consume it again. A real treatment or cure would free patients from this lifelong dietary restriction.

By the time visible symptoms of Parkinson's appear, significant neurological damage has usually already occurred, limiting how much treatment can help. Detecting the disease years earlier could open the door to more effective intervention.

Kidney disease often advances silently for years before symptoms appear, and by the time it's caught, treatment options are limited mainly to slowing further decline. Catching and reversing it earlier remains an open medical challenge.

Drug-resistant tuberculosis requires longer, more expensive, and more toxic treatment regimens that many patients in affected regions simply can't access or complete. This keeps a preventable disease deadly in the parts of the world least equipped to fight it.

Ovarian cancer is often called a silent disease because symptoms don't appear until it has advanced significantly. Early detection tools remain far behind those available for other common cancers.

Fatty liver disease and cirrhosis often progress silently until liver function is severely compromised, leaving transplant as the only real option for many patients. A way to reverse earlier-stage liver damage could prevent countless transplants.